nextAI was established in 2020 by three clinicians and medical academics to support their data-driven, evidence-informed decisions on the diagnosis, prognosis, and treatment of Chronic Musculoskeletal Pain, Connective Tissue Disease, Juvenile Idiopathic Arthritis, and Osteoarthritis.
At nextAI, evidence is a foundational component of who we are.
Incorporating evidence and digital into everything we do is mission-critical to us.
Data-driven precision medicine supported by AI clinical studies can usher in an era of evidence-based, sustainable care, and revolutionize how data from clinical trials is used to personalize and optimize treatments.
It's about time.
CLINICAL RESEARCH TEAM
Ali Noorani MBBS, BSc (Hons), MRCS, FRCS (Trauma & Orth)
Co-Founder, CEO and President nextAI UK & EU
Ali is Consultant Trauma & Orthopaedic Surgeon Shoulder, Elbow & Upper Limb for the Upper Limb Service (Shoulder & Elbow) at St Bartholomew's and the Royal London Hospital at Barts Health NHS Trust, Medical Director and Chairman for Orthopaedic Specialists, President and Chairman for The Harley Street Specialist Hospital, Co- Founder of The Regenerative Clinic and Chief Medical Advisor for JS Healthcare Division
LinkedIn Profile: https://www.linkedin.com/in/ali-noorani-0419511/
Co-Founder and Chief Medical Officer
Nima is Lead for Limb Reconstruction, Consultant Foot, Ankle and Limb Reconstruction Surgeon at The Royal London Limb Reconstruction Service of Royal London Hospital / Barts Health NHS Trust. He is also the Co-founder and Head of Research of The Regenerative Clinic and Co-founder and senior Partner of Orthopaedic Specialists.
LinkedIn Profile: https://www.linkedin.com/in/nima-heidari-5683113a/
Stefano Olgiati, DSc (Epi), FRSM, PhD (Biostat), MSc (Hons), ACE (MIT)
Co-Founder and Chief AI Officer
Stefano is a Collaborator of the Institute for Health Metrics and Evaluation (IHME) Global Burden of Disease, and a Fellow of the Royal Society of Medicine (London, UK), of the Harvard Medical School and Harvard Medical PGME (Boston, MA, USA), of the Massachusetts Institute of Technology and Massachusetts Institute of Technology Sloan (Cambridge, MA, USA). He is the EiR and Moderator for Digital Health of Harvard Alumni Entrepreneurs (Boston, MA, USA), and a Professor of Computational Medicine and Advanced Biostatistics at the State University of Ferrara (Italy, EU).
LinkedIn Profile: https://www.linkedin.com/in/stefano-olgiati-020665/
Brady Fish, MBA
General Manager and President nextAI US & Americas
Brady is an accomplished business professional with extensive experience and a proven record of tackling challenging strategic problems in a variety of industries. Brady has worked within diverse organizations, including some of the largest and most cutting edge medical hospitals in the United States, the Veterans Administration, large state government entities, and one of the largest law firms in the world. His education and experience include the Harvard Medical School and Harvard Medical PGME program (Boston, MA, USA), a Masters in Business Administration from the University of Massachusetts (Amherst, MA, USA), is a member of the Harvard Alumni Entrepreneurs association (Boston, MA, USA), is currently the co-founder and lead consultant for a medical consulting firm (Haddonfield, NJ, USA), and the co-founder and CEO of an augmented reality solutions platform (Haddonfield, NJ, USA).
LinkedIn Profile: https://www.linkedin.com/in/bradyfish/
Federico Vasoli, JD
Independent General Counsel
Federico is the Managing Partner of the legal and tax advisory firm dMTV Global, with offices in Singapore, Malta, and Vietnam. He assists large groups and HNWIs, as well as small and medium enterprises and tech start-ups, based virtually in any jurisdiction, primarily in dealing with blockchains and IoT, wealth management and funds. His firm’s track-record includes assisting over 50 blockchain-related projects in two years in Singapore and Malta.
LinkedIn Profile: https://www.linkedin.com/in/federicovasoli/
Michael O’Regan, Ph.D
Biotech & Biopharma Advisor
Michael brings to the table a strong scientific background, extensive international marketplace experience and a proven track-record of accomplishing challenging strategic business goals in the Pharmaceutical, Biotechnology and Medical Device industries. In a career spanning more than three decades, Michael has worked within diverse global corporate cultures in medium- to large-size companies including Transgene SA, Fidia Pharmaceuticals, Wright Medical, Anika Therapeutics, Regen Lab SA, Bonesupport AB and Regenerative Medicine LLC. He has held management positions in areas covering the entire product lifecycle from development to commercialization. During this time, Michael has become particularly skilled in bridging the gap between medical technology and the marketplace.
LinkedIn Profile: https://www.linkedin.com/in/michael-o-regan-phd-52a3394/